$7.12
4.35% yesterday
Nasdaq, Apr 11, 09:51 pm CET
ISIN
US21874A1060
Symbol
CORZ

Core Scientific Target price 2025 - Analyst rating & recommendation

Core Scientific Classifications & Recommendation:

Buy
94%
Hold
6%

Core Scientific Price Target

Target Price $19.03
Price $7.07
Potential
Number of Estimates 16
16 Analysts have issued a price target Core Scientific 2026 . The average Core Scientific target price is $19.03. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 17 analysts: 16 Analysts recommend Core Scientific to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Core Scientific stock has an average upside potential 2026 of . Most analysts recommend the Core Scientific stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 510.67 501.89
1.65% 1.72%
EBITDA Margin 21.33% 28.59%
4.13% 34.02%
Net Margin -251.54% -12.92%
564.45% 94.86%

16 Analysts have issued a sales forecast Core Scientific 2025 . The average Core Scientific sales estimate is

$502m
Unlock
. This is
1.72% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$650m 27.32%
Unlock
, the lowest is
$339m 33.66%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $511m 1.65%
2025
$502m 1.72%
Unlock
2026
$946m 88.58%
Unlock
2027
$1.3b 40.92%
Unlock
2028
$1.7b 27.74%
Unlock
2029
$3.0b 75.04%
Unlock

15 Analysts have issued an Core Scientific EBITDA forecast 2025. The average Core Scientific EBITDA estimate is

$143m
Unlock
. This is
31.72% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$259m 137.46%
Unlock
, the lowest is
$-2.8m 102.54%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $109m 2.55%
2025
$143m 31.72%
Unlock
2026
$381m 165.28%
Unlock
2027
$561m 47.38%
Unlock
2028
$859m 53.15%
Unlock

EBITDA Margin

2024 21.33% 4.13%
2025
28.59% 34.02%
Unlock
2026
40.22% 40.68%
Unlock
2027
42.06% 4.57%
Unlock
2028
50.43% 19.90%
Unlock

14 Core Scientific Analysts have issued a net profit forecast 2025. The average Core Scientific net profit estimate is

$-64.8m
Unlock
. This is
96.00% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$49.7m 103.07%
Unlock
, the lowest is
$-149m 90.79%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-1.3b 575.38%
2025
$-64.8m 94.95%
Unlock
2026
$93.9m 244.86%
Unlock
2027
$174m 85.51%
Unlock
2028
$279m 60.08%
Unlock
2029
$414m 48.33%
Unlock

Net Margin

2024 -251.54% 564.45%
2025
-12.92% 94.86%
Unlock
2026
9.92% 176.78%
Unlock
2027
13.06% 31.65%
Unlock
2028
16.37% 25.34%
Unlock
2029
13.87% 15.27%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -4.39 -0.22
575.38% 94.99%
P/E negative
EV/Sales 4.83

14 Analysts have issued a Core Scientific forecast for earnings per share. The average Core Scientific EPS is

$-0.22
Unlock
. This is
96.03% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$0.17 103.07%
Unlock
, the lowest is
$-0.51 90.79%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-4.39 575.38%
2025
$-0.22 94.99%
Unlock
2026
$0.32 245.45%
Unlock
2027
$0.60 87.50%
Unlock
2028
$0.95 58.33%
Unlock
2029
$1.41 48.42%
Unlock

P/E ratio

Current -1.28 103.91%
2025
-31.91 2,392.97%
Unlock
2026
22.03 169.04%
Unlock
2027
11.88 46.07%
Unlock
2028
7.42 37.54%
Unlock
2029
5.00 32.61%
Unlock

Based on analysts' sales estimates for 2025, the Core Scientific stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.75
2025
4.83 1.67%
Unlock
2026
2.56 46.97%
Unlock
2027
1.82 29.04%
Unlock
2028
1.42 21.71%
Unlock
2029
0.81 42.87%
Unlock

P/S ratio

Current
2025
4.15 1.75%
Unlock
2026
2.20 46.97%
Unlock
2027
1.56 29.04%
Unlock
2028
1.22 21.71%
Unlock
2029
0.70 42.87%
Unlock

Current Core Scientific Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Canaccord Genuity
Locked
Locked
Locked Mar 12 2025
HC Wainwright & Co.
Locked
Locked
Locked Mar 11 2025
Cantor Fitzgerald
Locked
Locked
Locked Feb 27 2025
Needham
Locked
Locked
Locked Feb 27 2025
HC Wainwright & Co.
Locked
Locked
Locked Feb 27 2025
Canaccord Genuity
Locked
Locked
Locked Feb 27 2025
Compass Point
Locked
Locked
Locked Feb 25 2025
Analyst Rating Date
Locked
Canaccord Genuity:
Locked
Locked
Mar 12 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Mar 11 2025
Locked
Cantor Fitzgerald:
Locked
Locked
Feb 27 2025
Locked
Needham:
Locked
Locked
Feb 27 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Feb 27 2025
Locked
Canaccord Genuity:
Locked
Locked
Feb 27 2025
Locked
Compass Point:
Locked
Locked
Feb 25 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today